Ep145 Adrian Jones Partner HSCM Ventures: We need to reconsider the word Insurtech

Today’s guest is one of the smartest people in the insurance
sector and I am really lucky to have been able to spend time
talking to him fairly regularly over the course of the last few
years. I first got to know him just as the whole insurtech
movement started to really take shape in around 2016 to 2017 and
ever since that time he’s always been open and honest about the
way he appraised the new wave of technological investment
sweeping through the industry. He never lost his critical
faculties and never got caught up in the hype that defined part
of that era. But that doesn’t mean he’s a sceptic either – he’s
actually quite a rare animal – an enthusiastic but realistic
adopter and promoter of better ways of doing the business of
insurance. Today’s episode is one I am really pleased with
because it does the job of a podcast properly. Over the years I
have had many enlightening conversations with Adrian just like
the one you are about to hear. But up until now I had never
recorded one. So prepare yourself for a masterclass in what the
smart money thinks about the state of insurtech. Embedded
insurance, insurtech bubbles – whether they existed and whether
they have now burst – how the hard reinsurance market will affect
start-ups and even the very logic of the phrase insurtech itself
are all addressed in the discussion. I’ll wager you’ll get more
benefit from listening to Adrian for 45 minutes than you will
from attending any 3-day Insurtech conference. LINKS We thank our
naming sponsor AdvantageGo: https://www.advantagego.com/


TRANSCRIPT
https://www.thevoiceofinsurance.com/post/ep145-adrian-jones-transcript
-------- The views expressed are the views of Adrian Jones as of
the date hereof. Hudson Structured Capital Management Ltd.
(“HSCM”) undertakes no responsibility to advise you of any
changes. Neither the podcast nor any of the information contained
herein constitutes an offer to sell, or a solicitation of an
offer to buy, any security or instrument in or to participate in
any trading strategy or investment vehicle. Past performance is
not indicative of future results. There can be no assurance that
any objectives can be achieved or are realistic in any given
market condition. This podcast may contain forward-looking
statements; such statements are subject to various risks and
uncertainties. Forward-looking statements reflect our views as of
such date with respect to possible future events. Actual results
could differ – perhaps materially – from those in the
forward-looking statements. The HSCM Public InsurTech Index
(HPIX) tracks the price movements of a portfolio of common equity
securities listed in the last 10 years by companies operating in
the United States insurance sector with novel business models
differentiated by technology. The HPIX components, currently 22
companies, describe themselves as having novel business models
differentiated by technology. The Index components also meet
certain criteria, defined in the Index Guideline (available at
Solactive.com), concerning minimum size, length of public
listing, geography, and certain other aspects of the business
model. The chart illustrates the price movements of HPIX starting
with an initial value of 100 on the first trading day of 2020.
Solactive AG (“Solactive”) is the licensor of HSCM Public
InsurTech Index (the “Index”). The financial instruments that are
based on the Index are not sponsored, endorsed, promoted or sold
by Solactive in any way and Solactive makes no  express or
implied representation, guarantee or assurance with regard to:
(a) the advisability in investing in the financial instruments;
(b) the quality, accuracy and/or completeness of the Index;
and/or (c) the results obtained or to be obtained by any person
or entity from the use of the Index. Solactive does not guarantee
the accuracy and/or the completeness of the Index and shall not
have any liability for any errors or omissions with respect
thereto. Notwithstanding Solactive’s obligations to its
licensees, Solactive reserves the right to change the methods of
calculation or publication with respect to the Index and
Solactive shall not be liable for any miscalculation of or any
incorrect, delayed or interrupted publication with respect to the
Index. Solactive shall not be liable for any damages, including,
without limitation, any loss of profits or business, or any
special, incidental, punitive, indirect or consequential damages
suffered or incurred as a result of the use (or inability to use)
of the Index. For more information about HSCM, including risks
and other disclosures, please refer to www.hscm.com.